Seer (SEER) Interest Expenses (2020 - 2026)
Seer (SEER) posted quarterly Interest Expenses of $28.1 million for Q1 2026, up 2825.18% year-over-year from $961000.0 in Q1 2025, and up 875.74% quarter-over-quarter from $2.9 million in Q4 2025.
Seer (SEER) Interest Expenses (2020 - 2026) Analysis & Trends
Seer's Interest Expenses history runs 7 years deep, the most recent figure standing at $28.1 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 2825.18% year-over-year to $28.1 million; the TTM figure through Mar 2026 stood at $28.1 million (up 395.26% YoY), while the FY2025 annual figure was $107.6 million, up 18.01% from the prior year.
- Interest Expenses for Q1 2026 stood at $28.1 million, up from $2.9 million in the prior quarter.
- The five-year high for Interest Expenses was $42.3 million in Q1 2022, with the low at $73000.0 in Q4 2022.
- The 5-year median for Interest Expenses is $4.0 million (2023), against an average of $13.1 million.
- The sharpest annual moves came in 2024 and 2026: Interest Expenses slumped 99.41% in 2024, then soared 2825.18% in 2026.
- Seer's Interest Expenses stood at $73000.0 in 2022, then soared by 1257.53% to $991000.0 in 2023, then surged by 251.66% to $3.5 million in 2024, then fell by 17.33% to $2.9 million in 2025, then soared by 875.74% to $28.1 million in 2026.
- Business Quant data shows SEER's Interest Expenses at $28.1 million in Q1 2026, $2.9 million in Q4 2025, and $5.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | 27.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.12 Mn |
| Jun 30, 2026 | 27.12 Mn |
| Mar 31, 2026 | 28.11 Mn |
| Mar 31, 2026 | 28.11 Mn |
| Dec 31, 2025 | 2.88 Mn |
| Dec 31, 2025 | 2.88 Mn |
| Sep 30, 2025 | 5.81 Mn |
| Sep 30, 2025 | 5.81 Mn |
| Jun 30, 2025 | 6.19 Mn |
| Jun 30, 2025 | 6.19 Mn |
| Mar 31, 2025 | 961,000.00 |
| Mar 31, 2025 | 961,000.00 |
| Dec 31, 2024 | 3.49 Mn |
| Dec 31, 2024 | 3.49 Mn |
| Sep 30, 2024 | 224,000.00 |
| Sep 30, 2024 | 224,000.00 |
| Jun 30, 2024 | 34.89 Mn |
| Jun 30, 2024 | 34.89 Mn |
| Mar 31, 2024 | 1.01 Mn |
| Mar 31, 2024 | 1.01 Mn |